Dawn Maroney (NASDAQ: ALHC) reports multiple 10b5-1 sales and RSU vesting
Rhea-AI Filing Summary
Alignment Healthcare insider Dawn Maroney reported proposed sales of Common Stock via Form 144. The filing lists shares acquired on 03/13/2024 through RSU vesting (32,500 shares) and on 03/13/2025 through RSU vesting (39,785 shares).
The filing also documents recent 10b5-1 sales attributed to Dawn Maroney, including 30000 shares on 03/16/2026, 29,113 shares on 03/12/2026 (proceeds $507,925.32), and multiple earlier 2026 executions such as 30000 shares on 02/17/2026 and 30000 shares on 01/15/2026. The schedule shows additional disposals in January and December 2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Multiple Rule 10b5-1 sales by Dawn Maroney are disclosed, with RSU vesting dates noted.
The filing lists RSUs that vested on 03/13/2024 (32,500 shares) and 03/13/2025 (39,785 shares), establishing the source of shares offered. It separately records numerous 10b5-1 executions in late 2025 and early 2026, with individual sale sizes up to 282,070 shares on 12/29/2025 as shown.
These sales are presented as plan-driven transactions; their market impact depends on trading cadence and remaining plan parameters. Subsequent filings may provide further details on any remaining plan authorizations or post-transaction holdings.